FOLLICULAR LYMPHOMA (FL)
Clinical trials for FOLLICULAR LYMPHOMA (FL) explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA (FL) trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA (FL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental Dual-Targeting cell therapy takes on tough lymphomas
Disease control Not yet recruitingThis early study tests a new type of immune cell therapy (bispecific AbTCR-T cells) in 3 adults with B-cell lymphoma that has not responded to or returned after at least two prior treatments. The cells are designed to recognize and attack two cancer markers (CD19 and CD22) at onc…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: EARLY_PHASE1 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New CAR-T therapy aims to tackle tough lymphoma
Disease control Not yet recruitingThis study tests a new treatment called TC011, which uses a patient's own immune cells modified to attack lymphoma cells. It is for adults with follicular lymphoma that has returned or not responded to at least two prior therapies. The main goal is to see how many patients' tumor…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: PHASE2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for lymphoma patients: experimental combo targets hard-to-treat cancer
Disease control Not yet recruitingThis study tests a new drug called SCTB35 combined with lenalidomide in people whose follicular lymphoma has returned or stopped responding to prior treatment. About 93 adults aged 18-80 will be randomly assigned to receive either the new combination or the standard rituximab-plu…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
Colombia launches first CAR-T trial for Hard-to-Treat blood cancers
Disease control Not yet recruitingThis study aims to bring CAR-T cell therapy to Colombia for people with certain blood cancers that have come back or not responded to treatment. It has two parts: first, setting up the necessary partnerships and facilities to produce the therapy locally, and second, a small trial…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: NA • Sponsor: GUSTAVO SALGUERO • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Chemo-Free triplet aims to improve outcomes in follicular lymphoma
Disease control Not yet recruitingThis study tests a new combination of three drugs (sonrotoclax, zanubrutinib, and rituximab) in people with follicular lymphoma who have not had treatment before. The goal is to see if this chemotherapy-free approach can cause the cancer to disappear completely and stay away long…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
15-Year Check-In: how safe is this CAR T-Cell therapy?
Knowledge-focused Not yet recruitingThis study follows 18 people who already received GF-CART01, a type of cell therapy for certain blood cancers like lymphoma. Researchers will monitor participants for up to 15 years to see if any serious side effects occur and how long the modified cells stay in the body. The goa…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Sponsor: GenomeFrontier Therapeutics TW Co., Ltd. • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC